Navigation Links
Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
Date:9/10/2007

HCM recognized by Massachusetts Alliance for Economic Development on the

basis of its strong contribution to Massachusetts economy

BURLINGTON, Mass., Sept. 10 /PRNewswire/ -- Hyaluron Contract Manufacturing (HCM), a leading provider of aseptic manufacturing services to companies in the pharmaceutical and biotechnology industries, announced today that it has been selected as a finalist for the 2007 Team Massachusetts Economic Impact Award. HCM is one of five companies from the greater Boston area that is being considered for this award based on its strong contribution to the Massachusetts economy since January 1, 2006.

"We are extremely pleased to be among the finalists for this award," stated Shawn Kinney, President of HCM. "To be considered along with some of the other finalists as well as past winners is quite an honor for us."

Since January of 2006, HCM has experienced significant growth, making it one of the fastest growing biotech manufacturers in the Commonwealth. In that time, HCM has invested over 2.25 million in facility expansion and has created nearly forty new jobs bringing its current headcount to eighty-five. In October of 2006, the company applied for a patent on its unique Bubble-free filling(TM) technology designed to reduce or eliminate the bubble inside a prefilled syringe.

HCM's future plans include the expansion of its current facility by at least 6,000 square feet and the addition of several new jobs, bringing the total number of employees to 100 by the end of 2007.

In its fourth year, the Team Massachusetts Economic Impact Award recognizes companies from across the Commonwealth for their outstanding contribution to the Massachusetts economy based on job and facility expansion as well as product launch and community involvement. Past winners include Boston Scientific, Bayer Diagnostics, and Wyeth Biopharmaceuticals.

About HCM:

Hyaluron Contract Manufacturing (HCM) is a leader in aseptic contract manufacturing of filled liquid parenterals and medical devices. Since 1999, HCM has been offering its customers-from newly established firms to large- scale commercial enterprises-innovative and unique solutions to all their aseptic formulation/fill needs. At the core of HCM's business is a commitment to quality, regulatory compliance and on-time delivery. HCM is located in Burlington MA. For further information, visit http://www.hyaluron.com.

Hyaluron Contract Manufacturing, Inc.

99 South Bedford Street

Burlington, MA 01803

Contact: Claudio Tracanna

Office Phone 781-270-7900 x 114

Cell Phone: 781-443-2850

Email ctracanna@hyaluron.com


'/>"/>
SOURCE Hyaluron Contract Manufacturing, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Small Tree Communications awarded $2.85M defense contract
2. Research consortium aims to bring security and defense contracts to Wisconsin
3. Johnson Controls unit lands contract for plug-in hybrid battery
4. Johnson Controls partnership wins new contract
5. Defense contract helps Plexus gain record profits
6. Orbitec will use $25 million Air Force contract to make small launch vehicle
7. WHIE receives state eHealth Initiative contract
8. State defensive on new Oracle contract
9. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
10. School districts contract with Lawson for new data processing software
11. Doyle says new contracts saving state more than $16 million annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):